| Literature DB >> 26139485 |
F Köckerling1, D Jacob2, W Wiegank2, M Hukauf3, C Schug-Pass2, A Kuthe4, R Bittner5.
Abstract
INTRODUCTION: To date, there are no prospective randomized studies that compare the outcome of endoscopic repair of primary versus recurrent inguinal hernias. It is therefore now attempted to answer that key question on the basis of registry data. PATIENTS AND METHODS: In total, 20,624 patients were enrolled between September 1, 2009, and April 31, 2013. Of these patients, 18,142 (88.0%) had a primary and 2482 (12.0%) had a recurrent endoscopic repair. Only patients with male unilateral inguinal hernia and with a 1-year follow-up were included. The dependent variables were intra- and postoperative complications, reoperations, recurrence, and chronic pain rates. The results of unadjusted analyses were verified via multivariable analyses.Entities:
Keywords: Complications; Inguinal hernia; Recurrent; TAPP; TEP
Mesh:
Year: 2015 PMID: 26139485 PMCID: PMC4757618 DOI: 10.1007/s00464-015-4318-3
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 4.584
Age and BMI of patients with endoscopic primary versus recurrent unilateral inguinal hernia repair in men
| Operation |
| |||
|---|---|---|---|---|
| Primary | Recurrent | |||
| Age (year) | Mean ± SD | 55.5 ± 15.5 | 59.0 ± 15.5 | <0.001 |
| BMI (kg/m2) | Mean ± SD | 25.8 ± 3.4 | 26.0 ± 3.4 | 0.107 |
Demographic and surgery-related parameters and risk factors of patients with endoscopic primary versus recurrent unilateral inguinal hernia repair in men
| Primary op | Recurrent op |
| |||
|---|---|---|---|---|---|
|
| % |
| % | ||
| ASA score | |||||
| I | 6231 | 34.35 | 621 | 25.02 | <0.001 |
| II | 9680 | 53.36 | 1437 | 57.90 | |
| III/IV | 2231 | 12.30 | 424 | 17.08 | |
| Defect size | |||||
| I | 2648 | 14.60 | 453 | 18.25 | <0.001 |
| II | 11,726 | 64.63 | 1599 | 64.42 | |
| III | 3768 | 20.77 | 430 | 17.32 | |
| EHS medial | |||||
| Ja | 6568 | 36.20 | 1235 | 49.76 | <0.001 |
| Nein | 11,574 | 63.80 | 1247 | 50.24 | |
| EHS lateral | |||||
| Ja | 13,420 | 73.97 | 1469 | 59.19 | <0.001 |
| Nein | 4722 | 26.03 | 1013 | 40.81 | |
| EHS femoral | |||||
| Ja | 322 | 1.77 | 83 | 3.34 | <0.001 |
| Nein | 17,820 | 98.23 | 2399 | 96.66 | |
| EHS scrotal | |||||
| Ja | 502 | 2.77 | 32 | 1.29 | <0.001 |
| Nein | 17,640 | 97.23 | 2450 | 98.71 | |
| Risk factors | |||||
| Total | |||||
| Ja | 4582 | 25.26 | 747 | 30.10 | <0.001 |
| Nein | 13,560 | 74.74 | 1735 | 69.90 | |
| COPD | |||||
| Ja | 866 | 4.77 | 165 | 6.65 | <0.001 |
| Nein | 17,276 | 95.23 | 2317 | 93.35 | |
| Diabetes | |||||
| Ja | 812 | 4.48 | 139 | 5.60 | 0.014 |
| Nein | 17,330 | 95.52 | 2343 | 94.40 | |
| Aortic aneurysm | |||||
| Ja | 50 | 0.28 | 17 | 0.68 | 0.002 |
| Nein | 18,092 | 99.72 | 2465 | 99.32 | |
| Immunosuppression | |||||
| Ja | 85 | 0.47 | 15 | 0.60 | 0.354 |
| Nein | 18,057 | 99.53 | 2467 | 99.40 | |
| Corticoids | |||||
| Ja | 139 | 0.77 | 21 | 0.85 | 0.627 |
| Nein | 18,003 | 99.23 | 2461 | 99.15 | |
| Nikotin abusus | |||||
| Ja | 2005 | 11.05 | 292 | 11.76 | 0.292 |
| Nein | 16,137 | 88.95 | 2190 | 88.24 | |
| Coagulopathy | |||||
| Ja | 195 | 1.07 | 36 | 1.45 | 0.103 |
| Nein | 17,947 | 98.93 | 2446 | 98.55 | |
| Antiplatelet therapy | |||||
| Ja | 1133 | 6.25 | 217 | 8.74 | <0.001 |
| Nein | 17,009 | 93.75 | 2265 | 91.26 | |
| Coumarin | |||||
| Ja | 296 | 1.63 | 48 | 1.93 | 0.277 |
| Nein | 17,846 | 98.37 | 2434 | 98.07 | |
Intra- and postoperative complications, complication-related reoperations, and 1-year follow-up results of patients with endoscopic primary versus recurrent unilateral inguinal hernia repair in men
| Unadjusted analysis | Primary op | Recurrent op |
| ||
|---|---|---|---|---|---|
|
| % |
| % | ||
| Intraoperative complications | |||||
| Yes | 232 | 1.28 | 33 | 1.33 | 0.849 |
| No | 17,910 | 98.72 | 2449 | 98.67 | |
| Postoperative complications | |||||
| Yes | 581 | 3.20 | 100 | 4.03 | 0.036 |
| No | 17,561 | 96.80 | 2382 | 95.97 | |
| Reoperation | |||||
| Yes | 153 | 0.84 | 33 | 1.33 | 0.023 |
| No | 17,989 | 99.16 | 2449 | 98.67 | |
| Recurrence | |||||
| Yes | 170 | 0.94 | 36 | 1.45 | 0.023 |
| No | 17,972 | 99.06 | 2446 | 98.55 | |
| Pain at rest | |||||
| Yes | 740 | 4.08 | 153 | 6.16 | <0.001 |
| No | 17,402 | 95.92 | 2329 | 93.84 | |
| Pain on exertion | |||||
| Yes | 1457 | 8.03 | 284 | 11.44 | <0.001 |
| No | 16,685 | 91.97 | 2198 | 88.56 | |
| Chronic pain requiring treatment | |||||
| Yes | 419 | 2.31 | 95 | 3.83 | <0.001 |
| No | 17,723 | 97.69 | 2387 | 96.17 | |
Multivariable analysis of postoperative complications
| Parameter |
| Category | OR | 95 % CI | |
|---|---|---|---|---|---|
| EHS scrotal | <0.001 | Yes versus no | 2.558 | 1.845 | 3.548 |
| Defect size | <0.001 | II (1.5–3 cm) versus I (<1.5 cm) | 1.603 | 1.202 | 2.138 |
| III (>3 cm) versus I (<1.5 cm) | 2.323 | 1.699 | 3.177 | ||
| Age (10-year OR) | <0.001 | 1.133 | 1.067 | 1.204 | |
| BMI (5-point OR) | <0.001 | 0.782 | 0.691 | 0.884 | |
| EHS lateral | <0.001 | Yes versus no | 0.645 | 0.499 | 0.834 |
| EHS medial | 0.001 | Yes versus no | 0.658 | 0.512 | 0.845 |
| Operation | 0.045 | Primary versus recurrent | 0.797 | 0.638 | 0.995 |
| ASA score | 0.067 | II versus I | 1.030 | 0.844 | 1.258 |
| III/IV versus I | 1.330 | 1.005 | 1.760 | ||
| Risk factors | 0.798 | Yes versus no | 0.976 | 0.814 | 1.172 |
| EHS femoral | 0.852 | Yes versus no | 1.052 | 0.617 | 1.792 |
Multivariable analysis of reoperation
| Parameter |
| Category | OR | 95 % CI | |
|---|---|---|---|---|---|
| EHS scrotal | 0.011 | Yes versus no | 2.266 | 1.204 | 4.264 |
| BMI (5-point OR) | 0.014 | 0.745 | 0.589 | 0.942 | |
| Operation | 0.019 | Primary versus recurrent | 0.630 | 0.428 | 0.927 |
| Defect size | 0.021 | II (1.5–3 cm) versus I (<1.5 cm) | 1.317 | 0.793 | 2.188 |
| III (>3 cm) versus I (<1.5 cm) | 1.970 | 1.130 | 3.436 | ||
| Age (10-year OR) | 0.047 | 1.122 | 1.001 | 1.257 | |
| Risk factors | 0.083 | Yes versus no | 1.337 | 0.963 | 1.858 |
| ASA score | 0.083 | II versus I | 0.821 | 0.563 | 1.197 |
| III/IV versus I | 1.263 | 0.759 | 2.103 | ||
| EHS femoral | 0.462 | Yes versus no | 1.405 | 0.568 | 3.480 |
| EHS lateral | 0.735 | Yes versus no | 1.082 | 0.686 | 1.704 |
| EHS medial | 0.798 | Yes versus no | 0.946 | 0.620 | 1.445 |
Multivariable analysis of recurrence in 1-year follow-up
| Parameter |
| Category | OR | 95 % CI | |
|---|---|---|---|---|---|
| BMI (5-point OR) | 0.004 | 1.304 | 1.089 | 1.562 | |
| EHS medial | 0.008 | Yes versus no | 1.682 | 1.144 | 2.471 |
| ASA score | 0.039 | II versus I | 0.955 | 0.675 | 1.352 |
| III/IV versus I | 1.598 | 0.981 | 2.603 | ||
| Operation | 0.069 | Primary versus recurrent | 0.710 | 0.491 | 1.027 |
| Defect size | 0.171 | II (1.5–3 cm) versus I (<1.5 cm) | 0.702 | 0.483 | 1.022 |
| III (>3 cm) versus I (<1.5 cm) | 0.801 | 0.510 | 1.258 | ||
| EHS scrotal | 0.204 | Yes versus no | 1.635 | 0.766 | 3.491 |
| Risk factors | 0.370 | Yes versus no | 0.858 | 0.614 | 1.199 |
| Age (10-year OR) | 0.649 | 1.025 | 0.921 | 1.140 | |
| EHS femoral | 0.702 | Yes versus no | 1.192 | 0.484 | 2.940 |
| EHS lateral | 0.984 | Yes versus no | 0.996 | 0.670 | 1.480 |
Multivariable analysis of pain at rest in 1-year follow-up
| Parameter |
| Category | OR | 95 % CI | |
|---|---|---|---|---|---|
| Operation | <0.001 | Primary versus recurrent | 0.661 | 0.550 | 0.794 |
| BMI (5-point OR) | <0.001 | 1.284 | 1.172 | 1.406 | |
| Defect size | <0.001 | II (1.5–3 cm) versus I (<1.5 cm) | 0.666 | 0.561 | 0.791 |
| III (>3 cm) versus I (<1.5 cm) | 0.551 | 0.437 | 0.694 | ||
| Age (10-year OR) | 0.056 | 0.952 | 0.905 | 1.001 | |
| EHS femoral | 0.154 | Yes versus no | 1.358 | 0.892 | 2.069 |
| Risk factors | 0.188 | Yes versus no | 1.113 | 0.949 | 1.305 |
| EHS scrotal | 0.410 | Yes versus no | 0.808 | 0.486 | 1.342 |
| ASA score | 0.446 | II versus I | 1.038 | 0.880 | 1.225 |
| III/IV versus I | 1.177 | 0.909 | 1.523 | ||
| EHS medial | 0.502 | Yes versus no | 0.931 | 0.755 | 1.147 |
| EHS lateral | 0.676 | Yes versus no | 1.050 | 0.835 | 1.320 |
Multivariable analysis of pain on exertion in 1-year follow-up
| Parameter |
| Category | OR | 95 % CI | |
|---|---|---|---|---|---|
| Operation | <0.001 | Primary versus recurrent | 0.667 | 0.581 | 0.765 |
| Age (10-year OR) | <0.001 | 0.834 | 0.804 | 0.865 | |
| Defect size | <0.001 | II (1.5–3 cm) versus I (<1.5 cm) | 0.721 | 0.635 | 0.819 |
| III (>3 cm) versus I (<1.5 cm) | 0.610 | 0.514 | 0.724 | ||
| BMI (5-point OR) | <0.001 | 1.175 | 1.096 | 1.259 | |
| EHS lateral | 0.149 | Yes versus no | 0.883 | 0.746 | 1.046 |
| EHS scrotal | 0.166 | Yes versus no | 0.766 | 0.525 | 1.117 |
| ASA score | 0.198 | II versus I | 1.062 | 0.943 | 1.195 |
| III/IV versus I | 1.198 | 0.984 | 1.459 | ||
| EHS medial | 0.466 | Yes versus no | 0.943 | 0.806 | 1.104 |
| Risk factors | 0.605 | Yes versus no | 1.032 | 0.916 | 1.163 |
| EHS femoral | 0.673 | Yes versus no | 1.076 | 0.766 | 1.510 |
Multivariable analysis of chronic pain requiring treatment in 1-year follow-up
| Parameter |
| Category | OR | 95 % CI | |
|---|---|---|---|---|---|
| Defect size | <0.001 | II (1.5–3 cm) versus I (<1.5 cm) | 0.502 | 0.408 | 0.619 |
| III (>3 cm) versus I (<1.5 cm) | 0.404 | 0.299 | 0.545 | ||
| BMI (5-point OR) | <0.001 | 1.405 | 1.257 | 1.570 | |
| Operation | <0.001 | Primary versus recurrent | 0.605 | 0.480 | 0.763 |
| Age (10-year OR) | <0.001 | 0.880 | 0.825 | 0.940 | |
| Risk factors | 0.027 | Yes versus no | 1.258 | 1.026 | 1.542 |
| ASA score | 0.261 | II versus I | 1.071 | 0.863 | 1.327 |
| III/IV versus I | 1.318 | 0.942 | 1.844 | ||
| EHS femoral | 0.332 | Yes versus no | 1.308 | 0.760 | 2.249 |
| EHS medial | 0.429 | Yes versus no | 0.893 | 0.675 | 1.182 |
| EHS scrotal | 0.668 | Yes versus no | 0.865 | 0.447 | 1.676 |
| EHS lateral | 0.960 | Yes versus no | 0.992 | 0.732 | 1.345 |